Lotimax RSS Authorised This medicine is authorised for use in the European Union lotilanerMedicineVeterinaryAuthorised
Page contentsPage contents Overview Product details Authorisation details Assessment history News on Lotimax More information on Lotimax Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website. Product details Name of medicine Lotimax Active substance lotilaner International non-proprietary name (INN) or common name lotilaner Pharmacotherapeutic groupEctoparasiticides for systemic use Authorisation details EMA product number EMEA/V/C/006441 Assessment history Initial marketing authorisation documents CVMP summary of positive opinion for LotimaxAdopted Reference Number: EMA/CVMP/99608/2024 English (EN) (124.54 KB - PDF)First published: 18/03/2024 View News on Lotimax Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 4-6 November 202507/11/2025 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 9-10 September 202512/09/2025 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 12-13 March 202418/03/2024 More information on Lotimax Credelio, Lotimax, Credelio Plus - opinion on variation to marketing authorisation This page was last updated on 17/06/2024 Share this page